IP Library Granted Patent US 8,933,035
Granted Patent B2
US 8,933,035 · App. 13/394,043 · Granted Jan 13, 2015

Transglutaminase-activating peptide and cosmetic or pharmaceutical composition containing same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,933,035
App. No.
13/394,043
Granted
Jan 13, 2015
Kind
B2
Abstract

A peptide of general formula (I): R 1 -(AA) n X 1 -X 2 -Arg-Arg-Gly-X 3 -X 4 -(AA) p -R 2 , and cosmetic and pharmaceutical compositions are disclosed that include at least one peptide of general formula (I), in a physiologically suitable medium. Also disclosed are methods for activating human transglutaminase to reinforce the skin barrier function and to stimulate epidermal regeneration and differentiation or for cosmetic treatment to treat signs of skin ageing, which include administering a composition containing the peptide of general formula (I) as an active ingredient.

Claims (14)

1. A method for protecting skin, the method comprising:

administering a composition containing a peptide of formula:

(SEQ ID NO: 2) Val-Ala-Arg-Arg-Gly-Gln-Pro-Phe-NH 2 ;

(SEQ ID NO: 5) Arg-Arg-Gly-Gln-NH 2 ; or

(SEQ ID NO: 7) Val-Val-Arg-Arg-Gly-Gln-NH 2

to reinforce the barrier function of the epidermis and to stimulate epidermal regeneration and differentiation, wherein administering the composition includes applying the composition before exposure to an external stress acting on the skin.

2. The method of claim 1 , wherein the composition comprises an effective amount of the peptide used alone or in combination with at least one other active ingredient.

3. The method of claim 1 , wherein the composition includes the peptide solubilized in one or more physiologically suitable solvents selected form the group consisting of water, glycerin, ethanol, propanediol, propylene glycol, butylene glycol, dipropylene glycol, ethoxylated diglycols, propoxylated diglycols, cyclic polyols, and combinations thereof.

4. The method of claim 1 , wherein the peptide is present in the composition at a concentration between approximately 0.0005 and 500 ppm.

5. The method of claim 4 , wherein said peptide is present at a concentration between approximately 0.01 and 5 ppm.

6. The method of claim 1 , wherein administering includes topically applying the composition.

7. The method of claim 2 , wherein the other active ingredient includes at least one of an antioxidant active ingredient, an active ingredient stimulating synthesis of dermal macromolecules, and an active ingredient stimulating energy metabolism.

8. The method of claim 1 , wherein administering the composition includes applying the composition for activating human transglutaminases of type 1, 2a, 2b, 3 or 5.

9. The method of claim 1 , wherein administering the composition includes topically applying the composition to skin before exposure to ultraviolet radiation, shaving or epilation.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CONVERSION Recorded Jan 30, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 041556/0499 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2012
From: DAL FARRA, CLAUDE; DOMLOGE, NOUHA; BOTTO, JEAN-MARIE
To: ISP INVESTMENTS INC.
Reel/Frame 028868/0083 →